[ad_1]
Novo Nordisk NVO reported its Q3 earnings results on Wednesday, November 2, 2022 at 01:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Novo Nordisk beat estimated earnings by 3.61%, reporting an EPS of $0.86 versus an estimate of $0.83.
Revenue was up $529.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 4.56% increase in the share price the next day.
Here’s a look at Novo Nordisk’s past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.82 | 0.80 | 0.71 | 0.78 |
| EPS Actual | 0.84 | 0.94 | 0.73 | 0.84 |
| Revenue Estimate | 5.81B | 5.59B | 5.67B | 5.35B |
| Revenue Actual | 5.91B | 6.34B | 5.90B | 5.64B |
To track all earnings releases for Novo Nordisk visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.